申请人:Abbott Laboratories and Ligand Pharmaceuticals Incorporated
公开号:US20030073703A1
公开(公告)日:2003-04-17
Compounds having Formula I
1
are useful for partially or fully antagonizing, repressing, agonizing, or modulating the glucocorticoid receptor and treating immune, autoimmune and inflammatory diseases in a mammal. Also disclosed are pharmaceutical compositions comprising compounds of Formula I and methods of inhibiting immune or autoimmune diseases in a mammal.
具有I1式的化合物对于部分或完全对抗、抑制、激动或调节糖皮质激素受体,并治疗哺乳动物的免疫、自身免疫和炎症性疾病是有用的。此外,还揭示了包含I式化合物的制药组合物和抑制哺乳动物的免疫或自身免疫疾病的方法。